Brain Glioblastoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2021-10-11
Clinical Trial Update: Phase 1/2a Study of BAL101553 as 48-hour Infusions in Patients With Advanced Solid Tumors or Recurrent Glioblastoma [Phase 1, Phase 2]
Phase 1/2a study of BAL101553 given as 48-hour infusions in adults with advanced solid tumors or recurrent glioblastoma has completed testin…